#United States #Boca Raton #Sage Dental #PerioStōm #Forward Science

Sage Dental and Forward Science's Innovative Partnership

In a groundbreaking move for dental care, Sage Dental has teamed up with Forward Science to introduce PerioStōm®, a revolutionary non-drug therapy designed to enhance recovery and outcomes for patients post-scaling and root planing (SRP) procedures. This pioneering collaboration aims to make dental treatments safer and more effective, especially for those requiring periodontal care.

Understanding PerioStōm®

PerioStōm® is an FDA-cleared treatment utilizing advanced chitosan microspheres that protect and promote healing of the oral mucosa following various dental procedures. Unlike traditional treatments, this innovative therapy does not rely on antibiotics, making it a safer and preferable option for patients. Chitosan, a natural biopolymer, works effectively in managing inflammation and healing, thus shortening recovery times and improving overall patient comfort.

This therapy represents a significant shift from conventional approaches, addressing a common concern among dental professionals: how to enhance healing without the associated risks of drug therapies. As dental practices increasingly focus on patient-centered care and outcomes, PerioStōm® stands out as a timely solution.

Clinical Implications of the Collaboration

The partnership between Sage Dental and Forward Science began in 2024 and has focused on evaluating the clinical impacts of PerioStōm® in actual patient settings. In a recent study involving patients undergoing SRP, those treated with the chitosan-based powder exhibited remarkable improvements over a 30-day follow-up. Metrics such as pocket depth reduction, bleeding on probing, and overall inflammation levels showed significant enhancements, indicating the efficacy of this innovative treatment.

Misty Mattingly, SVP and Chief of Dental Hygiene Operations at Sage Dental, stated, "At Sage Dental, our commitment to advancing patient care through innovation has always been a priority. The conception of PerioStōm® during Forward Science's Moving Science Forward Summit in 2018 was a pivotal moment for us. We are proud to offer a product that not only yields excellent results but is implemented at the earliest sign of disease to preserve dental health."

Leadership Sharing Vision

Robert J. Whitman, CEO of Forward Science, expressed his enthusiasm regarding the collaboration, noting, "We are excited to work alongside Sage Dental in bringing such a transformative product to market. Their leadership in the dental field and dedication to improving patient care aligns perfectly with our mission."

As PerioStōm® becomes available to dental practices nationwide, practitioners can expect a noticeable enhancement in the treatment of periodontal disease, leading to quicker patient recoveries and overall better treatment outcomes.

Sage Dental's Commitment to Quality Care

Sage Dental has been a trusted leader in dental care across the Southeastern U.S., serving over one million patients with a broad network of more than 140 practices. The organization is known for delivering high-quality clinical expertise and patient-centered solutions that encompass general, specialty, and cosmetic dental services.

With their participation in various dental plans and flexible payment options, Sage Dental ensures that comprehensive and innovative dental care remains accessible to a diverse patient population.

Practices interested in adopting PerioStōm® can easily reach out to Sage Dental while media inquiries can be directed to their dedicated contacts.

For further details about their services or to explore partnership opportunities, visit www.mysagedental.com or follow them on social media at @MySageDental.

In conclusion, the collaboration between Sage Dental and Forward Science marks a significant milestone in dental care, empowering both practitioners and patients with cutting-edge advancements aimed at fostering better dental health.